Loading...

Institute of Biomedical Research Corp.

MRESPNK
Healthcare
Biotechnology
$0.009
$-0.00(-6.50%)

Institute of Biomedical Research Corp. (MRES) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.
EPS (TTM)
$-4.14
P/E Ratio
-
ROE
1.05%
Net Margin
23.71%

Key Financial Metrices

Valuation Metrics

4 metrics
Market CapTotal market value of outstanding shares
$23.51M
Shares OutstandingTotal number of shares issued
$2.40B
Book Value/ShareNet worth per share
$0.001
Revenue/ShareAnnual revenue per share
$0.00

Profitability Metrics

6 metrics
EPS (TTM)Earnings per share trailing twelve months
$-4.14
Net MarginNet income as percentage of revenue
2371.35%
Operating MarginOperating income as percentage of revenue
-3568.48%
ROEReturn on shareholders' equity
105.22%
ROAReturn on total assets
33.77%
ROCEReturn on capital employed
-65.29%

Cash Flow Metrics

3 metrics
Free Cash Flow/ShareCash generated per share after capex
-
Cash/ShareCash and equivalents per share
$0.00
FCF YieldFree cash flow as percentage of market cap
-

Dividend Metrics

2 metrics
Dividend/ShareAnnual dividend payment per share
-
Dividend YieldAnnual dividend as percentage of stock price
-
Financial Ratios Analysis data is not available for MRESFinancial Ratios Analysis details for MRES are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Sector Benchmarking data is not available for MRESSector Benchmarking details for MRES are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Institute of Biomedical Research Corp. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Institute of Biomedical Research Corp.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Institute of Biomedical Research Corp.'s unique business strengths and challenges.

Key Financial Metrics for Institute of Biomedical Research Corp.

For Institute of Biomedical Research Corp., essential financial indicators include EPS -4.14, PE -, and ROE 1.05. These key ratios reveal insights into Institute of Biomedical Research Corp.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Institute of Biomedical Research Corp. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Institute of Biomedical Research Corp.

Metrics like Net Margin 2371.35% and ROA 33.77% shed light on how well Institute of Biomedical Research Corp. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Institute of Biomedical Research Corp. can sustain its operations and continue growing in the future.

Valuation and Market Position of Institute of Biomedical Research Corp.

Using ratios such as P/B Ratio 19.23 and PEG Ratio -1.29, investors can assess whether Institute of Biomedical Research Corp. is appropriately valued based on its financials and growth potential. These figures, combined with Institute of Biomedical Research Corp.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Institute of Biomedical Research Corp.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow -, provide a snapshot of Institute of Biomedical Research Corp.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Institute of Biomedical Research Corp., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Institute of Biomedical Research Corp.

Investing in Institute of Biomedical Research Corp. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Institute of Biomedical Research Corp. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;